Przewalskinic acid A exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory mediators such as nitric oxide and prostaglandin E2 in macrophage cells. It has been studied for its potential use in managing chronic inflammatory diseases due to its ability to suppress key signaling pathways like NF-κB. Additionally, it shows moderate cytotoxic effects against certain cancer cell lines, suggesting possible application in anticancer research. Its natural origin and bioactivity make it a candidate for development as a phytochemical therapeutic agent.